Integrity / innovation / cooperation / sharing / win-win
Products
It is a nucleotide analogue developed by Bioenvision and manufactured by Genzyme. On December 29, 2004, it was approved by FDA for the treatment of refractory or relapsed acute lymphoblastic leukemia (ALL) in children.
View detailsUpadacitinib(Scientific research)
Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-oriented and realizes industrial development through R&D innovation and technology transformation.
View detailsBrigatinib(Scientific research)
Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-oriented and realizes industrial development through R&D innovation and technology transformation.
View detailsAbemaciclib(Scientific research)
Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-oriented and realizes industrial development through R&D innovation and technology transformation.
View details
Follow WeChat
Anhui Union Pharmaceuticals Technology Co., Ltd.
Service line:
+86-21-54285906
E-mail：2880705932@qq.com
Add：4th Floor, Building B3, Creative Industry Park, Hefei, Anhui P. R. China.
Copyright © 2022 Anhui Union Pharmaceuticals Technology Co., Ltd.